Johnson & Johnson given go-ahead for bankruptcy strategy on talc lawsuits
.
Over the current book year the total revenue will be 96.33 billion USD (consensus estimates). This is slightly more than 2021's revenue of 93.78 billion USD.
Historical revenues and results Johnson & Johnson plus estimates 2021
The analysts expect for 2021 a net profit of 27.24 billion USD. The majority of the analysts expects for this year a profit per share of 10.26 USD. The price-earnings-ratio equals 17.41.
Analysts expect a dividend of 4.45 USD per share. Johnson & Johnson 's dividend yield thus equals 2.49 percent. The average dividend yield of the pharmaceutical companies is a limited 1.37 percent.
Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 470.27 billion USD. 11
At 16.05 the stock trades 0.24 percent lower at 178.64 USD.Historical stock prices Johnson & Johnson period 2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
